Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2003
11/13/2003CA2483806A1 N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders
11/13/2003CA2483573A1 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists
11/13/2003CA2483478A1 Factor vii or viia polypeptide variants
11/13/2003CA2483084A1 Tyrosine kinase inhibitors
11/13/2003CA2482784A1 Composition for treating cancer containing n,n-dimethylphytosphingosine
11/12/2003EP1361225A1 Compounds substituted with bicyclic amino groups
11/12/2003EP1360959A1 Use of 8-prenylflavanones for anti-angiogenesis therapy and for fibrinolytic therapy
11/12/2003EP1360508A2 Prediction of wound healing by urinary nitrate assay
11/12/2003EP1360486A2 Screening method for identifying compounds that selectively induce interferon alpha
11/12/2003EP1360295A2 Molecules for desease detection and treatment
11/12/2003EP1360205A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use
11/12/2003EP1360184A1 Piperidinee derivatives as neurokinin 1 antagonists
11/12/2003EP1360178A2 Novel heterocyclic analogs of diphenylethylene compounds
11/12/2003EP1360175A1 1g(a)-amino-n-hydroxy-acetamide derivatives
11/12/2003EP1360174A1 Phenethanolamine derivatives for treatment of respiratory diseases
11/12/2003EP1360173A2 Trisubstituted carbocyclic cyclophilin binding compounds and their use
11/12/2003EP1360170A1 Carboxylic amides, the production and use thereof as medicaments
11/12/2003EP1360167A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use
11/12/2003EP1359938A2 Method for treating psoriasis by using an il-17d antagonist
11/12/2003EP1359927A1 Herbal pharmaceutical compositions for treating immunological disorders
11/12/2003EP1359923A1 Use of selenite or preparations containing selenite for treating wounds
11/12/2003EP1359907A2 Combination comprising an insulin secretion enhancer and an active ingredient selected from hmg-co-a reductase inhibitors and ace inhibitors
11/12/2003EP1359905A2 Use of mglur5 antagonists for the treatment of pruritic conditions
11/12/2003EP1359897A2 Cosmetic composition and method for reducing or preventing wrinkling
11/12/2003EP1359885A1 Nos inhibitors for treatment of wrinkles
11/12/2003EP1282614B1 Hydroxamic acid derivatives
11/12/2003EP1206444B1 Compounds that inhibit tryptase activity
11/12/2003EP1206265B1 Src kinase inhibitor compounds
11/12/2003EP1181286B1 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides
11/12/2003EP1115707B1 Benzamide derivatives and ther use as cytokine inhibitors
11/12/2003EP1069886B1 Use of a topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, for providing a prolonged effect of an incorporated active substance
11/12/2003EP0906078B1 Topical use of tempol in the prevention of photoaging
11/12/2003EP0775203B1 Method of gene therapy using dna vectors without selection marker gene
11/12/2003CN1455780A New retinol derivatives, method of preparation and uses thereof
11/12/2003CN1455779A Clycerophosphoinositol derivatives as modulators of cytosolic phospholipase
11/12/2003CN1455772A Preventive or remedial agent for allergic disease and medical water-based liquid preparation, eye drop and nasal drop
11/12/2003CN1455677A Skin wound healing promoters
11/12/2003CN1455674A Use of sheep's parapoxvirus bacterial strain for preparing anti-virus medicines and anti-cancer medicine
11/12/2003CN1455672A Use of 2-methylene-19-Nor-20(s)-1 alpha, 25-dihydroxy vitamin D3 to increase bone strength
11/12/2003CN1455661A New cosmetic, personal care, cleaning agent and nutritional supplement compositions containg bioactive glass and methods of making and using same
11/12/2003CN1454662A Wart-removing ointment
11/12/2003CN1454659A Safflower oil
11/12/2003CN1454658A Tinea-wiping and pox-removing skin-nursing lotion
11/12/2003CN1454656A Medicine for curing leuconychia and hand-foot ringworm and preparing method thereof
11/12/2003CN1454654A Hair-growing liquid of natural plants and compounding method thereof
11/12/2003CN1454653A Wound medicine
11/12/2003CN1454639A Skin-haemorrhoids-clearing ointment and preparing method thereof
11/12/2003CN1454638A Sun-shielding cream and manufacturing method thereof
11/12/2003CN1454637A Chapstick and preparing method thereof
11/12/2003CN1454617A Body-building fast-acting hair-growing compound instant particles and preparing method thereof
11/12/2003CN1454602A High water-soluble povidone-iodine cream
11/12/2003CN1127511C Inhibitors of interleukin-1 ÔÇ£betaÔÇØ converting enzyme
11/12/2003CN1127487C Phthalazinone and its use, and drug containing same
11/12/2003CN1127480C Colchicine derivative and its treatment use
11/12/2003CN1127350C Cyclosorin-containing soft capsule preparations
11/12/2003CN1127348C Leukoderma treatmeng medicine and its preparation
11/12/2003CN1127346C Leukoderma treating externally-used medicine
11/12/2003CN1127345C Process for preparing liquid medicine to care verrucosis and gonorrhea
11/12/2003CN1127333C Local pharmaceutical composition comprising cholinergic agent or calcium channel blocker
11/11/2003US6646149 Derivitives of spermine or its N12-t-butyl carbamate
11/11/2003US6646143 Anticancer agents; skin disorders
11/11/2003US6646129 Cyanoguanidines as cell proliferation inhibitors
11/11/2003US6646108 Process for isolating IgG and IgA
11/11/2003US6646009 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
11/11/2003US6646005 Administering nontoxic sulfur compounds such as 3,5-dibromo-4-(4-hydroxy-3-iodophenylsulfonyl)phenylacetic acid, having side effect reduction; alopecia
11/11/2003US6645998 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
11/11/2003US6645997 Agonists of peroxisome proliferator activated receptor (PPAR) alpha and/or gamma
11/11/2003US6645991 αvβ3 integrin inhibitors
11/11/2003US6645990 For prophylaxis and therapy of diseases, such as cell proliferation or apoptosis mediated diseases
11/11/2003US6645977 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ACh receptors
11/11/2003US6645974 Androgen receptor modulators and methods for use thereof
11/11/2003US6645968 Potassium channel openers
11/11/2003US6645950 Benzimidazole vascular damaging agents
11/11/2003US6645933 Polypeptide that binds extracellular domain of human Flt4 receptor tyrosine kinase; genetic engineering; endothelial cell growth factors and genes
11/11/2003US6645531 Halting, diminishing, or inhibiting the growth of at least one of a bacterium, a fungus; a parasitic microbe, and a virus, which method comprises administering at least one electron active compound
11/11/2003US6645513 Treatment of skin with adenosine or adenosine analog
11/11/2003US6645509 Treating the thinning of the epidermis with said polypeptide
11/11/2003US6645476 Preparable by free-radical copolymerization of macromonomers containing an end-group capable of polymerization, a hydrophilic moiety based on polyalkylene oxides, and a hydrophobic moiety with olefincally unsaturated comonomers
11/11/2003CA2377118C Antipsoriatic compositions, method of making, and method of using
11/11/2003CA2290332C Optically pure androgen mediator
11/11/2003CA2262086C Use of a dehydroepiandrosterone derivative for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue
11/11/2003CA2185932C Use of a least one peptide in a cosmetic composition or for the preparation of a drug
11/06/2003WO2003091456A1 A dna enzyme to inhibit plasminogen activator inhibitor-1
11/06/2003WO2003091429A1 Antimicrobial polypeptide and utizliation thereof
11/06/2003WO2003091274A2 Use of alpha-s2 casein precursor-derived peptided
11/06/2003WO2003091271A1 Alternatively spliced nucleic acid molecules
11/06/2003WO2003091259A1 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors
11/06/2003WO2003091258A1 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/06/2003WO2003091257A1 [1,4]DIAZOCINO [7,8,1-hi]INDOLE DERIVATIVES AS ANTIPSYCHOTIC AND ANTIOBESITY AGENTS
11/06/2003WO2003091251A1 1,2,3,4,7,8-hexahydro-6h-[1,4]diazepino[6,7,1-1j]quinoline derivatives as antipsychotic and antiobesity agents
11/06/2003WO2003091247A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
11/06/2003WO2003091245A1 4,4-disubstituted piperidine derivatives having ccr3 antagonism
11/06/2003WO2003091229A1 Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors
11/06/2003WO2003091227A1 Tachykinin receptor antagonists
11/06/2003WO2003091226A1 Triazole derivatives as tachykinin receptor antagonists
11/06/2003WO2003091225A1 Substituted pyrazine derivatives
11/06/2003WO2003091224A1 Quinazoline derivative and medicine
11/06/2003WO2003091223A1 Pyrimidine derivative
11/06/2003WO2003091215A1 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo’ b! thiophene-2-carboxylic acid derivatives as interieukin-4 gene expression inhibitors
11/06/2003WO2003091214A1 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo
1 ... 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 ... 1065